Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1383

1.

Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.

Vanassche T, Verhamme P, Anand SS, Shestakovska O, Fox KA, Bhatt DL, Avezum A, Alings M, Aboyans V, Maggioni AP, Widimsky P, Berkowitz SD, Yusuf S, Connolly SJ, Eikelboom JW, Bosch J.

Eur J Prev Cardiol. 2019 Oct 15:2047487319882154. doi: 10.1177/2047487319882154. [Epub ahead of print]

PMID:
31615291
2.

Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis.

Solo K, Lavi S, Kabali C, Levine GN, Kulik A, John-Baptiste AA, Fremes SE, Martin J, Eikelboom JW, Ruel M, Huitema AA, Choudhury T, Bhatt DL, Tzemos N, Mamas MA, Bagur R.

BMJ. 2019 Oct 10;367:l5476. doi: 10.1136/bmj.l5476.

3.

Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.

Shapiro MD, Maron DJ, Morris PB, Kosiborod M, Sandesara PB, Virani SS, Khera A, Ballantyne CM, Baum SJ, Sperling LS, Bhatt DL, Fazio S.

J Am Coll Cardiol. 2019 Oct 15;74(15):1926-1942. doi: 10.1016/j.jacc.2019.08.1016. Review.

PMID:
31601373
4.

Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort study.

Arora S, Qamar A, Gupta P, Vaduganathan M, Chauhan I, Tripathi AK, Sharma VY, Bansal A, Fatima A, Jain G, Batra V, Tyagi S, Khandelwal L, Kaul P, Rao SV, Girish MP, Bhatt DL, Gupta MD.

Clin Cardiol. 2019 Oct 8. doi: 10.1002/clc.23278. [Epub ahead of print]

5.

Reply: Ischemic Event Reduction and Triglycerides.

Bhatt DL, Steg PG, Miller M, Juliano RA, Ballantyne CM.

J Am Coll Cardiol. 2019 Oct 8;74(14):1849-1850. doi: 10.1016/j.jacc.2019.08.007. No abstract available.

PMID:
31582151
6.

Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.

Ball S, Ghosh RK, Wongsaengsak S, Bandyopadhyay D, Ghosh GC, Aronow WS, Fonarow GC, Lenihan DJ, Bhatt DL.

J Am Coll Cardiol. 2019 Oct 1;74(13):1714-1727. doi: 10.1016/j.jacc.2019.07.079. Review.

PMID:
31558256
7.

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.

Tomaniak M, Chichareon P, Onuma Y, Deliargyris EN, Takahashi K, Kogame N, Modolo R, Chang CC, Rademaker-Havinga T, Storey RF, Dangas GD, Bhatt DL, Angiolillo DJ, Hamm C, Valgimigli M, Windecker S, Steg PG, Vranckx P, Serruys PW; GLOBAL LEADERS Trial Investigators.

JAMA Cardiol. 2019 Sep 26. doi: 10.1001/jamacardio.2019.3355. [Epub ahead of print]

PMID:
31557763
8.

Aortic Valve Replacement in Bioprosthetic Failure:Insights from The Society of Thoracic Surgeons National Database.

Kalra A, Raza S, Hussain M, Shorbaji K, Delozier S, Deo SV, Khera S, Kleiman NS, Reardon MJ, Kolte D, Gupta T, Mustafa R, Bhatt DL, Sabik JF 3rd.

Ann Thorac Surg. 2019 Sep 23. pii: S0003-4975(19)31407-9. doi: 10.1016/j.athoracsur.2019.08.023. [Epub ahead of print]

PMID:
31557477
9.

Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry.

Divakaran S, Singh A, Biery D, Yang J, DeFilippis EM, Collins BL, Ramsis M, Qamar A, Hainer J, Klein J, Cannon CP, Polk DM, Plutzky J, Nasir K, Januzzi JL, Di Carli MF, Bhatt DL, Blankstein R.

Diabetes Care. 2019 Sep 23. pii: dc190998. doi: 10.2337/dc19-0998. [Epub ahead of print]

PMID:
31548242
10.

Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Wanamaker BL, Seth MM, Sukul D, Dixon SR, Bhatt DL, Madder RD, Rumsfeld JS, Gurm HS.

J Am Heart Assoc. 2019 Oct;8(19):e013551. doi: 10.1161/JAHA.119.013551. Epub 2019 Sep 24.

11.

THEMIS and THEMIS-PCI.

Bhatt DL, Steg PG.

Eur Heart J. 2019 Sep 23. pii: ehz707. doi: 10.1093/eurheartj/ehz707. [Epub ahead of print] No abstract available.

PMID:
31545357
12.

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin.

Eikelboom JW, Bosch JJ, Connolly SJ, Shestakovska O, Dagenais GR, Hart RG, Leong DP, O'Donnell M, Fox KAA, Bhatt DL, Cairns JA, Tasto C, Berkowitz SD, Cook Bruns N, Muehlhofer E, Diaz R, Maggioni AP, Yusuf S.

J Am Coll Cardiol. 2019 Sep 24;74(12):1519-1528. doi: 10.1016/j.jacc.2019.07.065.

13.

Association of Acute Venous Thromboembolism With In-Hospital Outcomes of Coronary Artery Bypass Graft Surgery.

Panhwar MS, Ginwalla M, Kalra A, Gupta T, Kolte D, Khera S, Bhatt DL, Sabik JF 3rd.

J Am Heart Assoc. 2019 Oct;8(19):e013246. doi: 10.1161/JAHA.119.013246. Epub 2019 Sep 19.

14.

Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial.

Byrne C, Pareek M, Vaduganathan M, Biering-Sørensen T, Qamar A, Pandey A, Olesen TB, Olsen MH, Bhatt DL.

Eur Heart J Cardiovasc Pharmacother. 2019 Sep 14. pii: pvz050. doi: 10.1093/ehjcvp/pvz050. [Epub ahead of print]

PMID:
31529024
15.

Cardiometabolic risk reduction after metabolic surgery.

Pareek M, Bhatt DL.

Curr Opin Cardiol. 2019 Nov;34(6):663-672. doi: 10.1097/HCO.0000000000000683.

PMID:
31524661
16.

Bleeding and New Cancer Diagnosis in Patients with Atherosclerosis.

Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, Cook Bruns N, Felix C, Fox KAA, Hart RG, Maggioni AP, Moayyedi P, O'Donnell M, Rydén L, Verhamme P, Widimsky P, Zhu J, Yusuf S; COMPASS investigators.

Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.041949. [Epub ahead of print]

PMID:
31510769
17.

Leadership in Cardiovascular Medicine.

Shaikh AA, Bhatt DL, Kalra A.

Eur Heart J. 2019 May 7;40(18):1395-1397. doi: 10.1093/eurheartj/ehz257. No abstract available.

PMID:
31506693
18.

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.

Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators.

Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1.

19.

Transcatheter Aortic Valve Replacement in Low-Risk Patients.

Tang GHL, Verma S, Bhatt DL.

Circulation. 2019 Sep 9;140(10):801-803. doi: 10.1161/CIRCULATIONAHA.119.041111. Epub 2019 Sep 3. No abstract available.

PMID:
31479314
20.

SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.

Hess DA, Terenzi DC, Trac JZ, Quan A, Mason T, Al-Omran M, Bhatt DL, Dhingra N, Rotstein OD, Leiter LA, Zinman B, Sabongui S, Yan AT, Teoh H, Mazer CD, Connelly KA, Verma S.

Cell Metab. 2019 Oct 1;30(4):609-613. doi: 10.1016/j.cmet.2019.08.015. Epub 2019 Aug 30.

PMID:
31477497
21.

Ticagrelor in Patients with Stable Coronary Disease and Diabetes.

Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators.

N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1.

PMID:
31475798
22.

Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.

Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S, Ference TB, Guo Q, Laufs U, Ruff CT, Cupido A, Hovingh GK, Danesh J, Holmes MV, Smith GD, Ray KK, Nicholls SJ, Sabatine MS.

JAMA. 2019 Sep 2. doi: 10.1001/jama.2019.14120. [Epub ahead of print]

PMID:
31475726
23.

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.

Roe MT, Li QH, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Harrington RA, Jukema JW, Lopez-Jaramillo P, Lopes RD, Louie MJ, Moriarty PM, Szarek M, Vogel R, White HD, Zeiher AM, Baccara-Dinet MT, Steg PG, Schwartz GG; ODYSSEY OUTCOMES Investigators.

Circulation. 2019 Sep 2. doi: 10.1161/CIRCULATIONAHA.119.042551. [Epub ahead of print] No abstract available.

PMID:
31475572
24.

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.

Berg DD, Wiviott SD, Scirica BM, Gurmu Y, Mosenzon O, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Johanson P, Johansson PA, Langkilde AM, Raz I, Braunwald E, Sabatine MS.

Circulation. 2019 Aug 31. doi: 10.1161/CIRCULATIONAHA.119.042685. [Epub ahead of print] No abstract available.

PMID:
31474116
25.

Fluorodeoxyglucose Uptake in Atheroma: Not So Simple.

Libby P, Bhatt DL, Di Carli M.

J Am Coll Cardiol. 2019 Sep 3;74(9):1233-1236. doi: 10.1016/j.jacc.2019.07.009. No abstract available.

PMID:
31466621
26.

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.

Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Harrington RA, Jukema JW, Kedev S, Letierce A, Moryusef A, Pordy R, Ramos López GA, Roe MT, Viigimaa M, White HD, Zeiher AM, Steg PG, Schwartz GG; ODYSSEY OUTCOMES Committees and Investigators.

J Am Coll Cardiol. 2019 Sep 3;74(9):1177-1186. doi: 10.1016/j.jacc.2019.07.015.

PMID:
31466614
27.

Cardiovascular risk reduction with icosapent ethyl.

Patel PN, Patel SM, Bhatt DL.

Curr Opin Cardiol. 2019 Nov;34(6):721-727. doi: 10.1097/HCO.0000000000000678.

PMID:
31464773
28.

Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.

Hohnloser SH, Steg PG, Oldgren J, Nickenig G, Kiss RG, Ongen Z, Navarro Estrada JL, Oude Ophuis T, Lip GYH, Nordaby M, Kleine E, Ten Berg JM, Bhatt DL, Cannon CP; RE-DUAL PCI Steering Committee and Investigators.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1553-1561. doi: 10.1016/j.jcin.2019.05.050.

PMID:
31439336
29.

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Jiao L, Tardif JC, Gregson J, Pocock SJ, Ballantyne CM; REDUCE-IT Investigators.

J Am Coll Cardiol. 2019 Aug 27;74(8):1159-1161. doi: 10.1016/j.jacc.2019.06.043. No abstract available.

30.

Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.

Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA; EMPA-HEART CardioLink-6 Investigators.

Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375. [Epub ahead of print]

PMID:
31434508
31.

Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study.

Angiolillo DJ, Bhatt DL, Lanza F, Cryer B, Dong JF, Jeske W, Zimmerman RR, von Chong E, Prats J, Deliargyris EN, Marathi U.

J Thromb Thrombolysis. 2019 Nov;48(4):554-562. doi: 10.1007/s11239-019-01933-7.

PMID:
31420787
32.

Intravenous Tissue Plasminogen Activator in Stroke Mimics.

Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005609. doi: 10.1161/CIRCOUTCOMES.119.005609. Epub 2019 Aug 15.

PMID:
31412730
33.

The Changing Landscape of Aortic Valve Replacement in the United States.

Gupta T, Kolte D, Khera S, Goel K, Villablanca PA, Kalra A, Abbott JD, Elmariah S, Fonarow GC, Rihal CS, Garcia MJ, Weisz G, Bhatt DL.

EuroIntervention. 2019 Aug 13. pii: EIJ-D-19-00381. doi: 10.4244/EIJ-D-19-00381. [Epub ahead of print]

34.

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers. Reply.

Bhatt DL, Pollack CV, Weitz JI.

N Engl J Med. 2019 Aug 8;381(6):586. doi: 10.1056/NEJMc1907521. No abstract available.

PMID:
31390508
35.

On the Pearls and Perils of Sub-Subspecialization.

Oren O, Gersh BJ, Bhatt DL.

Am J Med. 2019 Jul 30. pii: S0002-9343(19)30604-7. doi: 10.1016/j.amjmed.2019.06.052. [Epub ahead of print] No abstract available.

PMID:
31369725
36.

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.

Bergmark BA, Bhatt DL, McGuire DK, Cahn A, Mosenzon O, Steg PG, Im K, Kanevsky E, Gurmu Y, Raz I, Braunwald E, Scirica BM; SAVOR-TIMI 53 Steering Committee and Investigators.

Circulation. 2019 Sep 17;140(12):1004-1014. doi: 10.1161/CIRCULATIONAHA.119.040144. Epub 2019 Jul 31.

PMID:
31362530
37.

Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.

Xian Y, Xu H, O'Brien EC, Shah S, Thomas L, Pencina MJ, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Hannah D, Maisch L, Lytle BL, Peterson ED, Hernandez AF.

JAMA Neurol. 2019 Jul 22. doi: 10.1001/jamaneurol.2019.2099. [Epub ahead of print]

PMID:
31329212
38.

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.

Inohara T, Liang L, Kosinski AS, Smith EE, Schwamm LH, Hernandez AF, Bhatt DL, Fonarow GC, Peterson ED, Xian Y.

J Am Heart Assoc. 2019 Aug 6;8(15):e012450. doi: 10.1161/JAHA.119.012450. Epub 2019 Jul 20.

39.

Hospital distance, socioeconomic status, and timely treatment of ischemic stroke.

Ader J, Wu J, Fonarow GC, Smith EE, Shah S, Xian Y, Bhatt DL, Schwamm LH, Reeves MJ, Matsouaka RA, Sheth KN.

Neurology. 2019 Aug 20;93(8):e747-e757. doi: 10.1212/WNL.0000000000007963. Epub 2019 Jul 18.

PMID:
31320472
40.

Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.

Flint AC, Conell C, Ren X, Banki NM, Chan SL, Rao VA, Melles RB, Bhatt DL.

N Engl J Med. 2019 Jul 18;381(3):243-251. doi: 10.1056/NEJMoa1803180.

PMID:
31314968
41.

Cardiovascular Biomarkers After Metabolic Surgery Versus Medical Therapy for Diabetes.

Bhatt DL, Aminian A, Kashyap SR, Kirwan JP, Wolski K, Brethauer SA, Hazen SL, Nissen SE, Schauer PR.

J Am Coll Cardiol. 2019 Jul 16;74(2):261-263. doi: 10.1016/j.jacc.2019.04.058. No abstract available.

PMID:
31296299
42.

Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention.

Olivier CB, Bhatt DL, Leonardi S, Stone GW, Gibson CM, Steg PG, Hamm CW, Wilson MD, Mangum S, Price MJ, Prats J, White HD, Lopes RD, Harrington RA, Mahaffey KW; CHAMPION PHOENIX Investigators * .

Circ Cardiovasc Interv. 2019 Jul;12(7):e007342. doi: 10.1161/CIRCINTERVENTIONS.118.007342. Epub 2019 Jul 12.

PMID:
31296081
43.

Meta-Analysis of Transcatheter Aortic Valve Replacement in Low-Risk Patients.

Kheiri B, Osman M, Bakhit A, Radaideh Q, Barbarawi M, Zayed Y, Golwala H, Zahr F, Stone GW, Bhatt DL.

Am J Med. 2019 Jul 8. pii: S0002-9343(19)30555-8. doi: 10.1016/j.amjmed.2019.06.020. [Epub ahead of print]

PMID:
31295442
44.

Comparison of Outcomes in Elective Endovascular Aortic Repair vs Open Surgical Repair of Abdominal Aortic Aneurysms.

Salata K, Hussain MA, de Mestral C, Greco E, Aljabri BA, Mamdani M, Forbes TL, Bhatt DL, Verma S, Al-Omran M.

JAMA Netw Open. 2019 Jul 3;2(7):e196578. doi: 10.1001/jamanetworkopen.2019.6578.

45.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

PMID:
31272931
46.

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Capodanno D, Huber K, Mehran R, Lip GYH, Faxon DP, Granger CB, Vranckx P, Lopes RD, Montalescot G, Cannon CP, Ten Berg J, Gersh BJ, Bhatt DL, Angiolillo DJ.

J Am Coll Cardiol. 2019 Jul 9;74(1):83-99. doi: 10.1016/j.jacc.2019.05.016. Review.

PMID:
31272556
47.

The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.

Yong CM, Sundaram V, Abnousi F, Olivier CB, Yang J, Stone GW, Steg PG, Michael Gibson C, Hamm CW, Price MJ, Deliargyris EN, Prats J, White HD, Harrington RA, Bhatt DL, Mahaffey KW; CHAMPION PHOENIX Investigators.

Clin Cardiol. 2019 Jun 29. doi: 10.1002/clc.23221. [Epub ahead of print]

48.

Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients.

Darmon A, Sorbets E, Ducrocq G, Elbez Y, Abtan J, Popovic B, Ohman EM, Röther J, Wilson PF, Montalescot G, Zeymer U, Bhatt DL, Steg PG; REACH Registry Investigators.

J Am Coll Cardiol. 2019 Jul 2;73(25):3281-3291. doi: 10.1016/j.jacc.2019.04.046.

PMID:
31248549
49.

Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial.

Anand SS, Eikelboom JW, Dyal L, Bosch J, Neumann C, Widimsky P, Avezum AA, Probstfield J, Cook Bruns N, Fox KAA, Bhatt DL, Connolly SJ, Yusuf S; COMPASS Trial Investigators.

J Am Coll Cardiol. 2019 Jul 2;73(25):3271-3280. doi: 10.1016/j.jacc.2019.02.079.

50.

Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program.

Valle JA, Glorioso TJ, Bricker R, Barón AE, Armstrong EJ, Bhatt DL, Rao SV, Plomondon ME, Serruys PW, Keppetein AP, Sabik JF, Dressler O, Stone GW, Waldo SW.

JAMA Cardiol. 2019 Jun 26. doi: 10.1001/jamacardio.2019.1923. [Epub ahead of print]

PMID:
31241721

Supplemental Content

Loading ...
Support Center